Banks and brokerages that handled fund products by Lime Asset Management Co. in a misselling scandal agreed to return investments made by consumers, in line with the advisory issued by the country's financial regulator.
Woori Bank, Hana Bank, Shinhan Investment Corp., and Mirae Asset Daewoo Co. said their boards accepted calls by the Financial Supervisory Service's dispute settlement board beginning late 2018 to provide full refunds.
The four companies initially contested the FSS board's advice.
Some 500 individual investors and 58 corporate investors could receive over 150 billion won if the four companies satisfy the claims.
Woori was asked to pay 65 billion won, Shinhan 42.5 billion won, Hana 36.4 billion won and Mirae Asset Daewoo 9.1 billion won.
Lime Asset is accused of either falsifying or insufficiently stating fund product information.
Meanwhile, the financial institutions were blamed for providing inaccurate information about Lime without conducting thorough checks on products.
The four financial institutions intend to take action against Lime, such as pursuing indemnification and compensation for damages incurred.
Lime executives have been arrested.


Toyota, Honda Shares Rise on Possible U.S.-Canada Auto Tariff Cut
Moody’s Upgrades Vodafone Hybrid Debt Ratings to Baa3
CK Hutchison Seeks $1.5 Billion From Panama Over Canal Ports
Moody’s Affirms NVIDIA Aa1 Rating as AI Data Center Guarantees Reach $105 Billion
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
Baidu Shares Sink to One-Year Low as Ad Weakness Overshadows AI Growth
Shein Targets $26B-$27B Valuation for Hong Kong IPO
Standard Chartered Expands Hedge Fund Access for Wealth Clients
Google to Buy Spirit Airlines Business Data for $10 Million to Train AI
Lockheed Martin Secures $153.5 Million in U.S. Defense Contracts
Goldman Sachs Names 9 Top Japanese Semiconductor and Electronics Stocks
Samsung Eyes $72 Billion Shareholder Return Plan as AI Chip Boom Fuels Profits
Alphabet Eyes First Australian Dollar Bond as AI Spending Drives Funding Push
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead
Coty Revenue Beats Estimates as Beauty Demand Holds Firm
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Hermès Stock Downgraded by RBC as Luxury Growth Premium Narrows 



